Compare Noble Corporation plc (NE) vs Revvity Inc (RVTY) Price & Performance

Noble Corporation (NE) trades at $42.36, up 3.39% on the day. The stock shows mixed signals with a bearish technical trend but positive analyst sentiment, evidenced by a consensus price target of $52.00. Recent earnings have been volatile, with a beat in Q1 2026 but misses in Q4 2025 and Q2 2026. Financially, the company reported 2025 revenue of $3.29 billion and net income of $216.72 million, though 2026 projections indicate a decline in both revenue and profitability. A key recent development is the securing of a long-term drilling contract in Ghana, extending utilization into 2027.

The outlook for NE is cautiously optimistic, supported by new contracts and a positive analyst consensus, but tempered by earnings volatility and a bearish technical setup. Investment opportunities lie in the potential upside to the price target and stable cash flows, while risks include inconsistent earnings performance and ongoing legal investigations noted in recent news. Investors should weigh contract wins against fundamental softness.

Revvity (RVTY) trades at $154.18, up 0.38% today and near its 52-week high of $158.28. The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for the last three quarters. Recent developments include the launch of a new diabetes screening kit in Europe and the acquisition of Human Cell Design to expand its metabolic disease research tools. Revenue remains stable around $2.9 billion, though net income margin is modest at 8.16%.

The outlook is positive with analyst consensus leaning buy (51.72%) and a price target of $132.13, though the current price exceeds it. Key opportunities include diagnostic growth and AI-driven demand, while risks involve premium valuation (P/E 73.15), margin pressures, and exposure to China market volatility. Earnings on November 3, 2026, will be critical for near-term direction.